IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $677 | -37.7% | 63,606 | -38.4% | 0.07% | -36.4% |
| Q1 2023 | $1,086 | +43.8% | 103,258 | +69.4% | 0.11% | +13.8% |
| Q4 2022 | $755 | -99.8% | 60,949 | +27.1% | 0.09% | +42.4% |
| Q3 2022 | $497,000 | +310.7% | 47,942 | +356.5% | 0.07% | +266.7% |
| Q2 2022 | $121,000 | -88.3% | 10,501 | -87.2% | 0.02% | -87.0% |
| Q1 2022 | $1,031,000 | +20.4% | 81,981 | -13.9% | 0.14% | -3.5% |
| Q3 2020 | $856,000 | -25.0% | 95,165 | +11.0% | 0.14% | +7.5% |
| Q4 2019 | $1,141,000 | +58.0% | 85,714 | +1.9% | 0.13% | +35.7% |
| Q3 2019 | $722,000 | +317.3% | 84,087 | +465.7% | 0.10% | +600.0% |
| Q4 2013 | $173,000 | +11.6% | 14,864 | -4.7% | 0.01% | -22.2% |
| Q2 2013 | $155,000 | – | 15,599 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |